this virus, designated EBfaV-GFP, are readily detected by their green fluorescence (9) (10) (11) .
Here, we report that cells of human breast cancer epithelial lines T47D and MCF7, which are not infected on direct exposure to cell-free EBfaV-GFP virus, become infected when cocultivated with LCLs derived with and bearing EBfaV-GFP, as shown by expression of EGFP. This finding is consistent with a possible role for EBV in the etiology of breast cancer.
EBfaV-GFP, with EGFP driven by a strong promoter, within a dispensable region of the viral genome is produced as described previously (10) . MCF7 and T47D cells (derived from human breast tumors) and Daudi cells (an LCL immortalized by and bearing wild-type Affiliation of authors: MicrobiologyImmunology Department, Northwestern University Medical School, Chicago, IL.
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© Oxford University Press Fig. 2  (panels 1 and 2 ). GFP57 and Daudi cells do not express ESA (panels 3 and 4). T47D and MCF7 cells are not infected by direct contact (Fig. 2 , panels 6 and 7) with a 100-L inoculum of cell-free EBfaV-GFP virus that contained sufficient virus to infect 20% of 10 5 Daudi cells, as measured by the proportion of cells expressing EGFP (Fig. 2, panel 5) .
To confirm that EGFP expression was occurring in breast epithelial cells in the monolayer and not in GFP57 cells, two-color flow cytometry was applied with the use of a marker present only on the epithelial cell population. Cells were removed, resuspended, and reacted with antibody 323/A3; infected epithelial cells-defined as positive for both ESA and EGFP-were then enumerated. Results (Fig. 2, panels 9 and  10) show that 1.1% and 3.4% of cocultivated MCF7 and T47D cells, respectively, were ESA positive and EGFP positive, confirming infection by cell-tocell contact. Control experiments, in which cocultivated breast cell monolayers with Daudi cells transiently expressed EGFP (Fig. 2 , panels 11 and 12), yielded minimal background (ഛ0.10%) of dual-positive cells. The same level of background was seen when EGFP-expressing Daudi cells and T47D or MCF7 cells were mixed immediately before flow cytometry, suggesting that the background level did not arise during cocultivation (data not shown).
To address the possibility that LCLs on cultivation yielded free virus that then infected by direct virus-cell contact, cocultivations were repeated with a blocking antibody. Antibody 72A1 against EBV glycoprotein gp350, when included in cocultivations at a range of concentrations (0-40 g/mL), the highest of which completely abrogates infection of Daudi cells by EBfaV-GFP virus, did not reduce the proportion of T47D or MCF7 cells that became infected (data not shown). We conclude that EBV cell-to-cell infection of these epithelial cells does not require the presence of free virus.
Efficient infection of T47D and MCF7 cells by cell-to-cell contact requires actively growing cells. Repeating cocultivation experiments with the use of completely confluent monolayers yielded cells positive for both ESA and EGFP numbering between 0.2% and 0.3% of total cells, which was two to three times the background level (data not shown).
Previous reports (7, 8) have shown that EBV infects epithelial cells by cellto-cell contact. Our observation is consistent with these findings and extends to breast epithelium the range of tissue types potentially infectible by EBV; it also supports the notion that virusbearing lymphocytes may serve as virus donors for infection of epithelial cells (8) . Cell-to-cell spread by fusion of infected cells with uninfected cells has been documented for other viruses, e.g., herpes simplex virus (13, 14) , pseudorabies virus (15) , human immunodeficiency virus (16) , and paramyxoviruses such as measles (17) . Although the current studies do not elucidate the mechanism of the cell-to-cell spread of EBV, fusion of infected cells with uninfected cells is a possible explanation for this phenomenon. Alternatively, close cell-to-cell contact could augment the accessibility of virus to recipient cells, possibly with viral attachment and entry via a hypothetical low-affinity receptor molecule or molecules. Examination of the mechanism will be a subject of future experiments. EBV association with epithelial tumors has been difficult to reconcile with the apparent inability of EBV virions to efficiently undergo direct entry into epithelial cells, which express little, if any, CD21 (the major receptor for EBV). These observations begin to address the difficulties in understanding a role for EBV in breast cancer etiology by demonstrating EBV entry into breast epithelium by cell-tocell contact.
